Results 141 to 150 of about 187,468 (310)

Factors associated with cardiovascular events after simultaneous liver–kidney transplant from the US Multicenter Simultaneous Liver–Kidney Transplant Consortium

open access: yesHepatology Communications, EarlyView., 2022
Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo   +19 more
wiley   +1 more source

Intravascular Lithotripsy in Left Main Stem Percutaneous Coronary Intervention

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background IVL is increasingly used for coronary calcium modification; however, prospective data for its use in LMS lesions are lacking. Aims To evaluate the feasibility, safety, and mechanical efficacy of intravascular lithotripsy (IVL) for calcium modification in calcified distal left main stem (LMS) percutaneous coronary intervention ...
Claudia S Cosgrove   +14 more
wiley   +1 more source

Statin-induced myopathy and the benefit of oral administration of coenzyme Q10

open access: yes, 2007
Background. Muscle cramps are one of the adverse affects suffered by hypercholesterolemia patients who are treated with statins. Besides reducing cholesterol levels, statins also reduce coenzyme Q10 (CoQ10) blood levels.
Dede Indra Kurniawan (23296171)
core  

Trans‐Patch Retrograde Re‐Entry During Hybrid Revascularization of an External Iliac Artery Chronic Total Occlusion: A Technical Note and Review of Re‐Entry Strategies

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Failure of true‐lumen re‐entry after subintimal wire passage is a well‐recognized limitation of endovascular treatment for external iliac artery (EIA) chronic total occlusions (CTO). We report a 73‐year‐old woman with severe limb ischemia and a prior failed endovascular attempt who underwent hybrid left common femoral artery (CFA ...
Bibhas Amatya, Dipankar Mukherjee
wiley   +1 more source

Statin-associated muscle symptoms (SAMS) in primary prevention for cardiovascular disease in older adults: a protocol for a systematic review and meta-analysis of randomised controlled trials

open access: yes, 2017
Introduction: Although statins are commonly used for prevention of cardiovascular disease, there is limited evidence about statin-related adverse effects in older people.
Zhen Zhou (14753959)   +4 more
core  

Risk of rheumatoid arthritis risk in statin users vs. non-statin users according to different populations.

open access: yes, 2018
Risk of rheumatoid arthritis risk in statin users vs. non-statin users according to different populations.
Henk van Loveren (314612)   +7 more
core   +1 more source

Coronary Plaque Phenotypes According to Physiological Disease Severity and Pullback Pressure Gradient

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary pressure pullback characterizes both the overall physiological severity and longitudinal distribution of coronary artery disease. However, the respective relationships of physiological disease severity and longitudinal disease distribution with local and vessel‐wide plaque phenotypes remain incompletely understood.
Takeshi Nishi   +9 more
wiley   +1 more source

Genetic Polymorphisms and Statin-Associated Side Effects: The Role of SLCO1B1 and Additional Risk Factors

open access: yesSoutheastern European Medical Journal
Statins are first-line agents for managing dyslipidemia, primarily prescribed to reduce low-density lipoprotein cholesterol (LDL-C) and prevent atherosclerotic cardiovascular disease (ASCVD).
Romana Marušić   +3 more
doaj   +1 more source

Statin prescription patterns, adherence, and attainment of cholesterol treatment goals in routine clinical care: a Danish population-based study

open access: yes, 2015
Elisabeth Svensson,1 Rikke Beck Nielsen,1 Pål Hasvold,2 Pernilla Aarskog,2 Reimar W Thomsen1 1Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark; 2AstraZeneca Nordic Baltic, Södert ...
Hasvold P   +4 more
core  

Statin equipotency.

open access: yes, 2015
Statin equipotency.
Yi-Heng Li (700379)   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy